ID
29673
Descripción
Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Lung function testing: Exhaled nitric oxide, pulmonary function tests, Methacholine Challenge. Time: Treatment Period 1, Day 29.
Link
https://clinicaltrials.gov/ct2/show/NCT00318630
Palabras clave
Versiones (1)
- 10/4/18 10/4/18 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
10 de abril de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Influence of PPAR gamma agonist vs. Placebo on allergen-induced late asthmatic response NCT00318630
Lung function testing - Treatment Period 1, Day 29
- StudyEvent: ODM
Descripción
Pulmonary function tests / FEV 1
Alias
- UMLS CUI-1
- C0024119
- UMLS CUI-2
- C0429706
Descripción
Date of FEV1
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0429706
Descripción
Time relative to Dosing.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0429706
Descripción
Hr : Min 00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
Descripción
Reading 1 of FEV1
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0456984
- UMLS CUI [1,2]
- C0429706
Descripción
Reading 2 of FEV1
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0456984
- UMLS CUI [1,2]
- C0429706
Descripción
Reading 3 of FEV1
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0456984
- UMLS CUI [1,2]
- C0429706
Descripción
Pulmonary function tests: Pre-Methacholine Challenge
Alias
- UMLS CUI-1
- C0024119
- UMLS CUI-2
- C0430567
- UMLS CUI-3
- C3812758
Descripción
pre-Methacholine pulmonary function test date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0024119
- UMLS CUI [1,3]
- C0430567
- UMLS CUI [1,4]
- C3812758
Descripción
Time relative to start of challenge. 3 pre-saline measurements are required.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0748133
Descripción
Time of FEV1
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
Descripción
FEV1 Reading
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0456984
- UMLS CUI [1,2]
- C0429706
Descripción
Pulmonary function tests: Methacholine Challenge
Alias
- UMLS CUI-1
- C0748133
- UMLS CUI-2
- C0430567
Descripción
Methacholine Challenge Date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0748133
- UMLS CUI [1,3]
- C0430567
Descripción
Inhaled Substance
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205535
- UMLS CUI [1,2]
- C0600370
- UMLS CUI [2,1]
- C0205535
- UMLS CUI [2,2]
- C0036082
Descripción
Following the baseline assessment in which FEV1 is measured after inhalation of saline, subjects are to inhale doubling increments of Methacoline (provocholine) until a ≥20 percent fall in FEV1 from the baseline saline value is achieved. 0.000 is the concentration value for saline.
Tipo de datos
text
Unidades de medida
- mg/mL
Alias
- UMLS CUI [1,1]
- C1446561
- UMLS CUI [1,2]
- C0600370
Descripción
Use this item, if historical concentrations instead of the concentrations given in the item "challenge concentration (New Subjects)" are used. Following the baseline assessment in which FEV1 is measured after inhalation of saline, subjects are to inhale doubling increments of Methacholine (provocholine) until a ≥20percent fall in FEV1 from the baseline saline value is achieved. Use 0.000 for saline inhaltation.
Tipo de datos
float
Unidades de medida
- mg/mL
Alias
- UMLS CUI [1,1]
- C1446561
- UMLS CUI [1,2]
- C0600370
Descripción
Fill in only for saline inhalation and new subjects.
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0001559
Descripción
Stop Time of Inhalation
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0001559
Descripción
Both timepoints must be filled after each inhalation. Time relative to stop time of inhalation.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0205535
- UMLS CUI [1,3]
- C0748133
Descripción
Pulmonary function time
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
Descripción
FEV1 Result
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0429706
- UMLS CUI [1,2]
- C0430567
Descripción
Pulmonary function tests: Post-Methacholine Challenge
Alias
- UMLS CUI-1
- C0231921
- UMLS CUI-2
- C0430567
- UMLS CUI-3
- C0439568
Descripción
Date of post-challenge FEV1
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0429706
- UMLS CUI [1,3]
- C0439568
Descripción
Time relative to end of challenge: Post-challenge 6 measurements are required.
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
- UMLS CUI [1,3]
- C0439568
Descripción
Record use of rescue Salbutamol on the Concomitant Medications page.
Tipo de datos
float
Unidades de medida
- L
Alias
- UMLS CUI [1,1]
- C0429706
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0439568
Similar models
Lung function testing - Treatment Period 1, Day 29
- StudyEvent: ODM
C2826247 (UMLS CUI [1,2])
C3700245 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0429706 (UMLS CUI-2)
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0430567 (UMLS CUI-2)
C3812758 (UMLS CUI-3)
C0024119 (UMLS CUI [1,2])
C0430567 (UMLS CUI [1,3])
C3812758 (UMLS CUI [1,4])
C0748133 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0430567 (UMLS CUI-2)
C0748133 (UMLS CUI [1,2])
C0430567 (UMLS CUI [1,3])
C0600370 (UMLS CUI [1,2])
C0205535 (UMLS CUI [2,1])
C0036082 (UMLS CUI [2,2])
C0600370 (UMLS CUI [1,2])
C0600370 (UMLS CUI [1,2])
C0001559 (UMLS CUI [1,2])
C0001559 (UMLS CUI [1,2])
C0205535 (UMLS CUI [1,2])
C0748133 (UMLS CUI [1,3])
C0429706 (UMLS CUI [1,2])
C0430567 (UMLS CUI [1,2])
C0430567 (UMLS CUI-2)
C0439568 (UMLS CUI-3)
C0429706 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0429706 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Sin comentarios